Engineered Host Cells for Membrane Protein Expression

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods face challenges in achieving high-level expression and correct orientation of membrane proteins in foreign host cells, leading to low yields and stability issues, which hinders structural and functional characterization and drug discovery efforts targeting membrane proteins.

Innovation Solution

A host cell system is developed, specifically engineered with mutations in exogenous nucleic acid molecules encoding membrane proteins like VKORc1 and host cell-specific mutations in genes such as dsbB, yidC, and ubiquinone biosynthesis genes, to enhance expression and functionality of membrane proteins in E. coli.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If membrane proteins are overexpressed in foreign host cells using conventional methods, then expression levels are increased, but mis-targeting and inclusion body formation occur leading to protein degradation or cell death

Engineering Contradiction:
Improveexpression levelVSAvoidprotein stability
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent applies parameter changes by modifying host cell genetic parameters (mutations in disulfide bond enzymes, insertases, ubiquinone biosynthesis genes, and cytoplasmic proteases) to create an optimized expression environment. These parameter changes in the host cell system enable high-level membrane protein expression while preventing mis-targeting and inclusion body formation, thereby maintaining protein stability and functionality.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If membrane proteins are overexpressed in foreign host cells, then more protein is produced, but correct orientation and assembly become more difficult to achieve

Engineering Contradiction:
Improvetotal yieldVSAvoidorientation accuracy
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent modifies host cell parameters by introducing specific mutations in genes encoding membrane insertion machinery components (insertases like YidC) and disulfide bond enzymes. These parameter changes in the host cell system facilitate correct membrane protein orientation and assembly during high-level expression, ensuring that topogenic signals are properly recognized and processed despite increased expression demands.

Inventive Principle:
Principle #35Parameter changes

3Ease of manufacture

If conventional expression systems are used for membrane proteins, then standard protocols can be applied, but conformational stability and functionality are compromised

Engineering Contradiction:
Improveprotocol standardizationVSAvoidconformational stability
Core Design Contradiction:
Ease of manufactureVSStability of the object's composition

Solution Approach 1:

The patent employs self-service by engineering the host cell system itself to provide the necessary conditions for membrane protein stability. Through mutations in disulfide bond enzymes and other host cell components, the system automatically ensures correct disulfide bond formation, proper folding, and conformational stability of expressed membrane proteins, eliminating the need for external stabilization measures while maintaining standardizable protocols.

Inventive Principle:
Principle #25Self-service

Data Source

PatentUS11319530B2Host cells and systems for membrane protein expression
Publication Date: 2022.05.03 PRESIDENT & FELLOWS OF HARVARD COLLEGE
  • US11319530B2 patent drawing
  • US11319530B2 patent drawing
  • US11319530B2 patent drawing

AI summary

Provided herein are host cells or host cellular expression systems that express a membrane protein. Also, methods are provided that use such host cells or host cellular expression systems to produce higher amounts of the membrane proteins. Further, the cells or cellular systems can be used as tools for the functional characterization of membrane proteins, as well as for screening and drug discovery efforts targeting membrane proteins.